Clearance Summary
CARESTART-PREGNANCY AND CARESTART PLUS-PREGNANCY received FDA 510(k) clearance under submission number K032159, sponsored by Access Bio Incorporate. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2003-09-05.
- Submission: K032159
- Applicant / Sponsor: Access Bio Incorporate
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1155
- Decision date: 2003-09-05
Classification & Regulation
This clearance is catalogued under FDA product code LCX and 21 CFR 862.1155, within the Clinical Chemistry review panel as a Class II device.